Posted on 4/10/19
PhaseBio Proposes Public Offering of Common Stock
MALVERN, Pa. and SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization . . .
Posted on 4/8/19
Horizon Technology Finance Provides $20 Million Venture Loan Facility to Encore Dermatology
Horizon Technology Finance Corporation (NASDAQ: HRZN), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in . . .
Posted on 4/8/19
AscellaHealth Named Among Top 10 Pharmacy Management Solution Providers
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth (Ascella), a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, is pleased to announce that for the second consecutive year, . . .
Posted on 4/8/19
Recro Pharma: Restructuring Points To Profits
SummaryRecro Pharma recently received its second CRL from the FDA regarding its IV Meloxicam product candidate. As a result, the company has announced a restructuring of . . .
Posted on 4/7/19
Cognition Therapeutics Adds Drs. Mary Sano and Philip Scheltens
Pittsburgh, April 05, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative . . .
Posted on 4/1/19
Realm Therapeutics Announces Completion of Assets Disposal
Realm Therapeutics plc (NASDAQ: RLM) today announces the completion of its previously announced Assets Disposal representing certain assets, which comprise the Vashe® wound care royalty stream, . . .
Posted on 3/28/19
ECRI Institute Opens International Medical Device Evaluation Center
ECRI Institute, an independent, trusted authority on medical practices and products, is launching its first medical device evaluation laboratory outside the United States. The ECRI International . . .
Posted on 4/8/19
Interview with Nick Ciccarelli, President of Neuma, LLC - Part II
Brought to you by Newmark Knight Frank
Posted on 4/11/19
Interview with Nick Ciccarelli, President of Neuma, LLC - Part III
Brought to you by Newmark Knight Frank
Posted on 4/7/19
Interview with Nick Ciccarelli, President of Neuma, LLC - Part I
Brought to you by Newmark Knight Frank
Posted on 3/25/19
Titan Medical and Teleflex Incorporated Announce Collaboration
TORONTO & WAYNE, Pa.--(BUSINESS WIRE)--Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a robotic surgical system . . .
Posted on 3/25/19
2019’s Best & Worst States for Doctors – WalletHub Study
Doctors are among the highest-paid and most educated professionals in the U.S. In fact, “physician” was the highest-paid job type in 2018, with a median base . . .
Posted on 3/20/19
Ariel Precision Medicine Named Life Sciences PA Emerging Company of the Year
Pittsburgh, March 19, 2019 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held, clinically integrated, genomics and health technology company developing innovative solutions for complex . . .
Posted on 3/20/19
Onconova Therapeutics to Provide Corporate Update
NEWTOWN, Pa., March 19, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to . . .
Posted on 3/19/19
New Study: Reusable Bronchoscopes Cost More Than Sterile Single-use Bronchoscopes
Study urges hospitals to consider obtaining sterile single-use bronchoscopes for routine procedures to improve hospital economy and patient safety. Bronchoscopes – one of the most commonly . . .
Posted on 3/14/19
PharmMD Changes Company Name to AdhereHealth
Reflects vision of better health through medication adherence by resolving social determinants through disruptive technologies, engagement services and home-delivered pharmacy PharmMD™, a leading healthcare technology company . . .
Posted on 3/13/19
Harmony Biosciences Secures $200 Million Debt Facility
Harmony Biosciences, LLC (Harmony) a private biopharmaceutical company dedicated to developing and commercializing novel treatment options for people living with rare diseases, announced today that it . . .
Posted on 3/7/19
Why Teva Pharmaceutical Industries Stock Sank in February
What happenedGeneric-drug giant Teva Pharmaceutical Industries (NYSE:TEVA) lost over 14% of its value during the month of February, according to data from S&P Global Market Intelligence. . . .
Posted on 3/6/19
Better Buy: Walmart vs. Rite Aid
Almost everyone knows that Walmart (NYSE:WMT) is one of the largest companies in the world. With over 11,000 global locations, it's a behemoth in more ways . . .
Posted on 3/5/19
Almirall to Divest ThermiGen
Almirall S.A. (ALM) announced that it has entered into a definitive agreement with Celling Biosciences, based in Austin (Texas), to divest ThermiGen for an undisclosed amount. . . .
Posted on 3/4/19
Inovio Pharmaceuticals Completes Sale of Additional Convertible Senior Notes
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the sale of additional 6.50% convertible senior notes due 2024, bringing the total amount of notes sold to $78.5 . . .
Posted on 2/21/19
Geneos Therapeutics Secures $10.5 Million in Series A
Geneos Therapeutics announced today that it has closed its Series A round raising $10.5 Million in financing.
Posted on 2/14/19
Inovio Pharmaceuticals Prices $65.0 Million Convertible Senior Notes Offering
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the pricing of its offering of $65.0 million aggregate principal amount of 6.50% convertible senior notes due 2024. The . . .
Posted on 2/14/19
Inovio Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today its intention to offer, subject to market and other conditions, $65 million aggregate principal amount of convertible senior notes . . .
Posted on 2/6/19
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RADNOR, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Pittsburgh
